Based on the latest National Comprehensive Cancer Network Guideline (27), PALB2 is categorized as a gene associated with breast cancer risk, whereas BRIP1 and RAD51C are categorized as genes associated with ovarian cancer risk. Here, PALB2 is linked to ovarian carcinoma.